Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics宣布与Lilly合作的里程碑，致力于发现和开发治疗ALS的新型治疗方法；Lilly将开发Verge Genomics确定的两个目标。
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics' AI-Enabled, All-in-Human CONVERGE Platform
— Demonstration of the Robust Predictive Power of CONVERGE - 83% of Prioritized Targets were Validated in Disease-Relevant Models, a Rate Significantly Higher than Industry Standards
资讯热榜
更新时间